Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

Clinical trial NCT00135993 · COMPLETED

Trial details

NCT number: NCT00135993
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2005-05-01
Primary completion: 2006-11-01
Enrollment: 811

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.